Previous studies have suggested a crucial role for protease-activated receptor 2 (PAR2), which is activated by proteases in the colonic tissues of IBS patients, as a mediator contributing to hypersensitivity symptoms [8–10]. This evidence concerns the gene F2RL1 and irritable bowel syndrome.